G
NVCR icon

GenTrust’s NovoCure NVCR Stock Holding History

GenTrust’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,000
Closed -$94K – 82
2016
Q4 		$94K Buy
+12,000
New +$96.5K 0.02% 83

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

GenTrust's NVCR Position: Q1 2017 in Review

GenTrust sold out of NovoCure (NVCR) in Q1 2017, closing a stake of 12,000 shares — an estimated $94K sold.

GenTrust first reported a position in NVCR in Q4 2016 and held it in 1 quarter. The position peaked at $94K in Q4 2016. 71 funds tracked by Wall St. Rank hold NVCR as of Q1 2017.

  • GenTrust reported no remaining NovoCure position as of Q1 2017 after selling out during the quarter.
  • GenTrust sold 12,000 NovoCure shares in Q1 2017, an estimated $94K.
  • GenTrust first reported a position in NovoCure in Q4 2016 and held it in 1 quarter.
  • GenTrust's NovoCure position peaked at $94K in Q4 2016.
  • 71 funds tracked by Wall St. Rank held NovoCure as of Q1 2017.

Based on GenTrust's 13F filing for Q1 2017, filed 15 May 2017.